SHOCKWAVE MED INC's ticker is SWAV and the CUSIP is 82489T104. A total of 168 filers reported holding SHOCKWAVE MED INC in Q3 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,182 | -27.4% | 21,002 | +4.1% | 0.01% | -28.6% |
| Q2 2023 | $5,757 | +12.6% | 20,170 | -14.5% | 0.01% | +7.7% |
| Q1 2023 | $5,111 | -16.6% | 23,591 | -20.8% | 0.01% | -18.8% |
| Q4 2022 | $6,127 | -99.9% | 29,795 | +36.0% | 0.02% | -5.9% |
| Q3 2022 | $6,092,000 | +45.4% | 21,911 | -0.0% | 0.02% | +54.5% |
| Q2 2022 | $4,189,000 | +1086.7% | 21,913 | +1271.3% | 0.01% | +1000.0% |
| Q1 2022 | $353,000 | +16.5% | 1,598 | -6.2% | 0.00% | 0.0% |
| Q4 2021 | $303,000 | -13.9% | 1,704 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $352,000 | +2.0% | 1,704 | -6.3% | 0.00% | 0.0% |
| Q2 2021 | $345,000 | +59.7% | 1,819 | +9.1% | 0.00% | 0.0% |
| Q1 2021 | $216,000 | +5.9% | 1,667 | -15.6% | 0.00% | – |
| Q4 2020 | $204,000 | +80.5% | 1,976 | +32.1% | 0.00% | – |
| Q3 2020 | $113,000 | +61.4% | 1,496 | 0.0% | 0.00% | – |
| Q2 2020 | $70,000 | +268.4% | 1,496 | +157.0% | 0.00% | – |
| Q1 2020 | $19,000 | -24.0% | 582 | 0.0% | 0.00% | – |
| Q4 2019 | $25,000 | – | 582 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prossimo Advisors, LLC | 18,758 | $3,735 | 8.81% |
| Matisse Capital | 22,175 | $4,415,043 | 3.12% |
| Atika Capital Management LLC | 116,500 | $23,195,150 | 3.04% |
| APEIRON CAPITAL Ltd | 18,300 | $3,643,530 | 2.44% |
| AtonRa Partners | 4,374 | $870,863 | 1.83% |
| Rhenman & Partners Asset Management AB | 81,000 | $16,127,100 | 1.74% |
| GILDER GAGNON HOWE & CO LLC | 549,173 | $109,340,363 | 1.66% |
| Eversept Partners, LP | 84,462 | $16,816,384 | 1.42% |
| Biondo Investment Advisors, LLC | 37,451 | $7,456,394 | 1.40% |
| DEEPWATER ASSET MANAGEMENT, LLC | 15,321 | $3,050,411 | 1.40% |